Premium
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL
Author(s) -
Bologna S,
Vander Borght T,
Briere J,
Ribrag V,
Damaj G. L,
Thieblemont C,
Feugier P,
Peyrade F,
Lebras L,
Coso D,
Sibon D,
Bonnet C,
Morschhauser F,
Ghesquieres H,
Becker S,
Olivier P,
Fabiani B,
Tilly H,
Haioun C,
Bastie J. N
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.5_2879
Subject(s) - medicine , clinical endpoint , chop , diffuse large b cell lymphoma , positron emission tomography , population , surrogate endpoint , gastroenterology , phases of clinical research , lymphoma , nuclear medicine , randomized controlled trial , oncology , surgery , clinical trial , environmental health